hg_22543.1

Basic information about the TSS

---

TSS ID: hg_22543.1 Species: human Chr: chr2		Start: 131105299 End: 131105312 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000628582.2 uc010zaq.3 AK302770 Distance: 0 GeneID: 55041 HGNC/MGI_ID: HGNC:19236 UniProt_ID: Q96CS7

Gene_name: pleckstrin homology domain containing B2 Gene_symbol: PLEKHB2 Gene_synonyms: EVT2 FLJ20783 Gene_source: HGNC:19236

TATA-Box annotation

---

Distance to TSS:	459
Nearest PromoterID:	NM_017958
Entrez ID:	55041
Nearest Unigene:	Hs.469944
Nearest Refseq:	NM_017958
Nearest Ensembl:	ENSG00000115762
Gene Name:	pleckstrin homology domain containing B2
Gene Alias:	EVT2
Gene Description:	pleckstrin homology domain containing B2
Gene Type:	protein-coding
CpG%:	0.14
GC%:	0.711443
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@PLEKHB2 p2@PLEKHB2
Sample		p1@PLEKHB2	p2@PLEKHB2
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	45.58	6.62
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	46.53	8.09
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	44.37	5.79
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	38.26	3.53
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	45.44	6.07
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	35.08	5.81
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	38.57	11.55
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	39.24	10.42
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	35.26	7.48
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	38.26	4.06
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	25.87	4.85
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	33.34	5.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	22.57	5.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	19.40	4.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	22.17	3.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	16.60	4.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	19.00	4.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	14.34	4.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	17.06	2.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	18.96	3.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	18.44	3.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	23.13	5.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	22.75	4.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	17.96	4.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	20.64	4.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	18.36	3.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	23.08	3.85
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	24.05	5.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	20.84	5.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	21.17	3.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	16.12	3.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	20.52	3.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	17.52	6.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	27.38	6.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	19.07	5.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	17.05	5.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	18.19	4.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	21.56	3.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	24.31	4.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	18.48	3.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	16.47	6.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	19.76	3.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	18.56	6.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	21.68	3.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	21.88	5.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	20.47	3.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	12.72	4.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	22.06	1.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	19.39	4.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	20.02	3.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	19.06	5.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	24.24	4.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	111.94	27.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	14.90	2.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	21.54	1.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	78.86	10.91
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	33.07	7.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	19.45	5.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	14.13	4.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	36.46	6.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	11.99	4.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	16.82	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	56.53	12.74
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	27.18	5.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	20.47	4.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	16.33	3.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	177.80	16.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	197.44	15.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	20.48	2.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	19.83	4.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	19.23	3.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	30.80	8.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	21.04	3.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	16.20	2.45
Adipocyte - breast, donor1	11376-118A8	28.83	6.65
Adipocyte - breast, donor2	11327-117E4	21.50	7.38
Adipocyte - omental, donor1	11473-119C6	26.59	5.85
Adipocyte - omental, donor2	11474-119C7	22.42	4.48
Adipocyte - omental, donor3	11475-119C8	17.42	6.36
Adipocyte - perirenal, donor1	11476-119C9	31.90	6.38
Adipocyte - subcutaneous, donor1	11259-116F8	9.90	7.70
Adipocyte - subcutaneous, donor2	11336-117F4	23.94	0.90
Adipocyte - subcutaneous, donor3	11408-118E4	9.04	3.13
Adipocyte differentiation, day04, donor1	13019-139D4	24.25	5.48
Adipocyte differentiation, day04, donor2	13022-139D7	25.22	7.72
Adipocyte differentiation, day04, donor3	13025-139E1	22.86	5.85
Adipocyte differentiation, day04, donor4	13028-139E4	19.99	5.29
Adipocyte differentiation, day08, donor1	13020-139D5	26.46	5.15
Adipocyte differentiation, day08, donor2	13023-139D8	35.83	9.36
Adipocyte differentiation, day08, donor3	13026-139E2	24.53	4.80
Adipocyte differentiation, day08, donor4	13029-139E5	21.70	7.23
Adipocyte differentiation, day12, donor1	13021-139D6	22.87	10.40
Adipocyte differentiation, day12, donor2	13024-139D9	30.89	9.29
Adipocyte differentiation, day12, donor3	13027-139E3	25.20	8.18
Adipocyte differentiation, day12, donor4	13030-139E6	21.62	6.09
Alveolar Epithelial Cells, donor1	11510-119G7	40.44	5.52
Alveolar Epithelial Cells, donor2	11590-120G6	8.96	3.23
Alveolar Epithelial Cells, donor3	11671-122G6	5.99	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	21.41	4.14
Amniotic Epithelial Cells, donor2	11613-122A2	6.69	6.69
Amniotic Epithelial Cells, donor3	11694-123A2	14.59	5.75
Anulus Pulposus Cell, donor1	11248-116E6	20.60	5.61
Anulus Pulposus Cell, donor2	11463-119B5	10.04	6.86
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	29.20	7.64
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	25.61	9.55
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	27.82	12.84
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	30.49	9.57
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	27.82	5.06
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	23.10	3.96
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	25.99	5.85
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	25.24	6.31
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	25.54	7.72
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	27.12	4.90
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	26.85	2.90
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	23.82	6.27
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	36.41	6.75
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	23.20	8.19
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	27.90	5.73
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	24.65	7.50
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	25.88	6.99
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	21.65	7.48
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	35.12	6.83
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	28.36	8.79
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	19.21	4.80
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	46.02	10.62
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	26.76	6.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	16.78	8.39
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	35.92	7.77
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	23.91	4.93
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	23.02	4.85
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	24.51	3.99
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	24.58	6.20
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	19.10	5.16
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	21.11	5.63
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	25.40	6.75
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	17.12	5.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	23.98	5.26
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	25.59	4.52
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	16.63	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	33.06	5.09
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	29.80	6.11
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	22.24	5.08
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	22.44	6.90
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	26.88	4.87
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	20.59	5.80
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	25.51	7.56
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	24.07	5.26
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	18.53	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	25.35	8.45
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	23.37	5.57
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	22.86	4.21
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	33.53	5.10
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	28.05	6.67
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	15.30	10.20
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	35.34	4.07
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	25.60	5.57
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	24.79	3.37
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	33.46	5.26
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	28.60	4.43
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	25.94	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	29.36	8.31
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	28.86	7.15
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	20.72	4.00
Astrocyte - cerebellum, donor1	11500-119F6	27.27	7.49
Astrocyte - cerebellum, donor2	11580-120F5	15.92	8.90
Astrocyte - cerebellum, donor3	11661-122F5	12.38	5.66
Astrocyte - cerebral cortex, donor1	11235-116D2	41.48	13.94
Astrocyte - cerebral cortex, donor2	11316-117D2	34.30	15.04
Astrocyte - cerebral cortex, donor3	11392-118C6	39.68	18.20
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	33.26	11.47
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	31.57	7.39
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	27.42	10.36
Basophils, donor1	12241-129G9	64.60	15.69
Basophils, donor2	12242-129H1	103.55	17.68
Basophils, donor3	12243-129H2	56.59	8.97
Bronchial Epithelial Cell, donor1	11511-119G8	21.34	6.25
Bronchial Epithelial Cell, donor2	11591-120G7	1.83	2.29
Bronchial Epithelial Cell, donor3	11672-122G7	21.52	21.52
Bronchial Epithelial Cell, donor4	11453-119A4	16.95	8.16
Bronchial Epithelial Cell, donor5	11457-119A8	18.72	7.69
Bronchial Epithelial Cell, donor6	11461-119B3	23.49	7.83
Bronchial Epithelial Cell, donor7	11769-123I5	28.61	8.64
Burkitt's lymphoma cell line:DAUDI	10422-106C8	44.31	6.70
Burkitt's lymphoma cell line:RAJI	10476-106I8	57.29	9.08
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	35.81	8.95
CD133+ stem cells - cord blood derived, pool1	12223-129E9	31.03	31.03
CD14+ Monocytes, donor1	11224-116B9	144.27	22.54
CD14+ Monocytes, donor2	11305-117B9	135.67	32.48
CD14+ Monocytes, donor3	11381-118B4	112.18	22.39
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	219.93	43.31
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	186.13	37.91
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	187.05	34.19
CD14+ monocytes - mock treated, donor1	11863-125A9	99.31	20.67
CD14+ monocytes - mock treated, donor2	11873-125C1	144.84	19.92
CD14+ monocytes - mock treated, donor3	11883-125D2	128.63	20.37
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	114.00	18.58
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	223.85	22.63
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	247.43	33.22
CD14+ monocytes - treated with BCG, donor1	11860-125A6	178.77	26.04
CD14+ monocytes - treated with BCG, donor2	11870-125B7	211.17	29.20
CD14+ monocytes - treated with BCG, donor3	11880-125C8	330.15	31.56
CD14+ monocytes - treated with Candida, donor1	11868-125B5	138.13	25.52
CD14+ monocytes - treated with Candida, donor2	11878-125C6	269.29	31.68
CD14+ monocytes - treated with Candida, donor3	11888-125D7	201.90	41.05
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	113.20	18.74
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	195.96	26.34
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	257.13	23.53
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	140.47	24.94
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	226.88	19.68
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	181.13	26.19
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	161.93	29.59
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	220.52	33.32
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	209.57	34.09
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	140.91	20.02
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	244.47	35.93
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	231.65	35.10
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	182.92	24.41
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	266.49	27.88
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	387.13	35.13
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	113.02	24.57
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	222.76	25.03
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	260.30	28.54
CD14+CD16+ Monocytes, donor1	11789-124B7	95.47	15.26
CD14+CD16+ Monocytes, donor2	11801-124D1	97.48	17.09
CD14+CD16+ Monocytes, donor3	11912-125G4	91.85	18.20
CD14+CD16- Monocytes, donor1	11788-124B6	128.63	26.16
CD14+CD16- Monocytes, donor2	11799-124C8	95.01	19.56
CD14+CD16- Monocytes, donor3	11910-125G2	122.86	24.30
CD14-CD16+ Monocytes, donor1	11790-124B8	75.53	11.74
CD14-CD16+ Monocytes, donor2	11800-124C9	77.29	12.08
CD14-CD16+ Monocytes, donor3	11911-125G3	93.69	10.11
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	38.61	8.13
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	46.10	14.24
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	44.53	9.32
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	50.64	11.19
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	34.84	12.33
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	49.84	4.21
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	43.14	12.55
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	50.09	13.18
CD19+ B Cells, donor1	11544-120B5	71.51	12.33
CD19+ B Cells, donor2	11624-122B4	55.86	5.08
CD19+ B Cells, donor3	11705-123B4	45.43	10.60
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	54.55	15.35
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	45.14	11.59
CD34+ Progenitors, donor1	11545-120B6	38.15	12.05
CD34+ Progenitors, donor2	11625-122B5	111.80	11.80
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	50.35	10.90
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	42.62	12.63
CD4+ T Cells, donor1	11225-116C1	103.55	16.07
CD4+ T Cells, donor2	11306-117C1	81.44	16.53
CD4+ T Cells, donor3	11382-118B5	72.59	13.42
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	85.25	10.98
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	73.44	11.45
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	63.24	10.35
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	64.00	12.80
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	66.02	14.75
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	56.04	23.07
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	73.70	11.13
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	63.21	17.45
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	54.17	15.96
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	75.31	10.31
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	60.44	9.08
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	72.60	11.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	58.61	13.07
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	34.91	11.01
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	30.41	13.70
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	77.50	14.68
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	73.96	14.47
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	55.59	21.52
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	74.17	13.54
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	54.15	12.35
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	55.48	10.09
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	61.68	17.70
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	61.95	10.40
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	61.45	16.56
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	63.34	19.79
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	63.70	11.08
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	55.83	11.17
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	59.54	18.55
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	64.54	18.90
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	81.62	26.18
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	62.31	21.85
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	74.79	12.46
CD8+ T Cells, donor1	11226-116C2	102.80	10.48
CD8+ T Cells, donor2	11307-117C2	78.09	12.76
CD8+ T Cells, donor3	11383-118B6	70.70	17.93
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	16.97	4.59
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	15.34	3.59
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	13.95	3.83
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	18.91	3.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	18.00	3.36
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	18.42	5.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	19.56	3.26
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	16.06	4.47
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	19.93	4.69
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	17.51	5.74
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	15.69	4.07
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	19.98	3.73
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	34.58	10.07
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	33.25	2.28
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	34.31	10.44
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	23.05	3.60
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	15.25	3.74
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	14.85	4.95
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	29.47	6.34
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	24.61	6.46
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	24.36	5.45
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	22.95	3.44
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	16.95	4.34
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	31.01	4.54
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	46.57	14.45
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	46.16	11.19
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	49.09	8.01
Cardiac Myocyte, donor1	11525-119I4	32.90	7.31
Cardiac Myocyte, donor2	11605-120I3	14.33	3.95
Cardiac Myocyte, donor3	11686-122I3	27.89	7.26
Chondrocyte - de diff, donor1	11261-116G1	42.99	11.09
Chondrocyte - de diff, donor2	11338-117F6	32.34	3.20
Chondrocyte - de diff, donor3	11410-118E6	22.87	5.58
Chondrocyte - re diff, donor2	11339-117F7	51.92	12.53
Chondrocyte - re diff, donor3	11411-118E7	17.39	6.47
Ciliary Epithelial Cells, donor1	11242-116D9	42.92	14.92
Ciliary Epithelial Cells, donor2	11323-117D9	30.35	10.26
Ciliary Epithelial Cells, donor3	11399-118D4	29.56	11.24
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	94.36	28.52
Corneal Epithelial Cells, donor1	11526-119I5	10.10	3.51
Corneal Epithelial Cells, donor2	11606-120I4	15.93	10.24
Corneal Epithelial Cells, donor3	11687-122I4	15.08	7.41
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	154.69	26.25
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	179.78	28.70
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	100.07	20.70
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	120.41	23.65
Dendritic Cells - plasmacytoid, donor1	11228-116C4	64.91	23.57
Dendritic Cells - plasmacytoid, donor2	11309-117C4	54.84	29.38
Dendritic Cells - plasmacytoid, donor3	11385-118B8	75.50	24.20
Endothelial Cells - Aortic, donor0	11207-116A1	33.85	7.50
Endothelial Cells - Aortic, donor1	11263-116G3	26.99	6.45
Endothelial Cells - Aortic, donor2	11340-117F8	22.62	3.68
Endothelial Cells - Aortic, donor3	11412-118E8	29.88	7.08
Endothelial Cells - Artery, donor1	11264-116G4	27.34	6.40
Endothelial Cells - Artery, donor2	11341-117F9	21.65	5.41
Endothelial Cells - Artery, donor3	11413-118E9	31.56	6.49
Endothelial Cells - Lymphatic, donor1	11236-116D3	44.55	6.43
Endothelial Cells - Lymphatic, donor2	11317-117D3	45.94	8.52
Endothelial Cells - Lymphatic, donor3	11393-118C7	52.72	5.92
Endothelial Cells - Microvascular, donor1	11265-116G5	30.01	5.65
Endothelial Cells - Microvascular, donor2	11342-117G1	41.65	6.77
Endothelial Cells - Microvascular, donor3	11414-118F1	12.05	5.67
Endothelial Cells - Thoracic, donor1	11266-116G6	47.61	5.20
Endothelial Cells - Thoracic, donor2	11343-117G2	22.01	6.81
Endothelial Cells - Umbilical vein, donor1	11243-116E1	43.73	8.95
Endothelial Cells - Umbilical vein, donor2	11324-117E1	21.29	9.13
Endothelial Cells - Umbilical vein, donor3	11400-118D5	30.17	10.50
Endothelial Cells - Vein, donor1	11267-116G7	21.61	11.38
Endothelial Cells - Vein, donor2	11344-117G3	32.83	4.89
Endothelial Cells - Vein, donor3	11416-118F3	25.44	7.85
Eosinophils, donor1	12244-129H3	76.23	0.00
Eosinophils, donor2	12245-129H4	249.19	79.21
Eosinophils, donor3	12246-129H5	142.67	67.77
Esophageal Epithelial Cells, donor1	11507-119G4	15.64	3.91
Esophageal Epithelial Cells, donor2	11587-120G3	27.04	4.16
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	16.27
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	30.38	9.85
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	22.66	3.61
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	22.53	5.85
Fibroblast - Aortic Adventitial, donor1	11245-116E3	51.54	8.85
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	50.36	8.87
Fibroblast - Aortic Adventitial, donor2	11326-117E3	23.94	5.27
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	30.83	5.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	26.58	8.30
Fibroblast - Cardiac, donor1	11268-116G8	27.22	7.26
Fibroblast - Cardiac, donor2	11345-117G4	33.35	2.27
Fibroblast - Cardiac, donor3	11417-118F4	22.71	4.42
Fibroblast - Cardiac, donor4	11452-119A3	26.37	6.37
Fibroblast - Cardiac, donor5	11456-119A7	31.98	7.99
Fibroblast - Cardiac, donor6	11460-119B2	32.59	8.19
Fibroblast - Choroid Plexus, donor1	11492-119E7	33.63	10.05
Fibroblast - Choroid Plexus, donor2	11572-120E6	16.39	7.77
Fibroblast - Choroid Plexus, donor3	11653-122E6	17.58	5.86
Fibroblast - Conjunctival, donor1	11531-120A1	19.14	5.07
Fibroblast - Conjunctival, donor3	11692-122I9	13.57	5.94
Fibroblast - Dermal, donor1	11269-116G9	33.57	9.16
Fibroblast - Dermal, donor2	11346-117G5	33.49	5.19
Fibroblast - Dermal, donor3	11418-118F5	23.69	6.29
Fibroblast - Dermal, donor4	11450-119A1	20.35	8.25
Fibroblast - Dermal, donor5	11454-119A5	19.54	13.08
Fibroblast - Dermal, donor6	11458-119A9	24.36	10.40
Fibroblast - Gingival, donor1	11237-116D4	43.10	9.16
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	22.53	5.76
Fibroblast - Gingival, donor2	11318-117D4	24.12	7.51
Fibroblast - Gingival, donor3	11394-118C8	23.69	5.41
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	27.01	7.27
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	18.68	4.93
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	25.26	7.64
Fibroblast - Gingival, donor6 (control)	11922-125H5	30.29	8.38
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	21.17	3.53
Fibroblast - Gingival, donor7 (control)	11924-125H7	24.42	8.04
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	28.09	9.95
Fibroblast - Gingival, donor8 (control)	11926-125H9	36.86	13.05
Fibroblast - Gingival, donor9 (control)	11927-125I1	18.49	7.34
Fibroblast - Lung, donor1	11270-116H1	19.03	4.08
Fibroblast - Lung, donor2	11347-117G6	13.43	10.45
Fibroblast - Lung, donor3	11419-118F6	15.41	5.70
Fibroblast - Lymphatic, donor1	11506-119G3	18.33	10.00
Fibroblast - Lymphatic, donor2	11586-120G2	13.99	1.40
Fibroblast - Lymphatic, donor3	11667-122G2	4.48	2.24
Fibroblast - Mammary, donor1	11540-120B1	36.54	11.37
Fibroblast - Mammary, donor2	11620-122A9	11.98	7.99
Fibroblast - Mammary, donor3	11701-123A9	0.00	11.91
Fibroblast - Periodontal Ligament, donor1	11238-116D5	29.10	6.40
Fibroblast - Periodontal Ligament, donor2	11319-117D5	19.11	6.37
Fibroblast - Periodontal Ligament, donor3	11395-118C9	55.08	8.87
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	27.10	7.25
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	35.91	8.64
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	22.27	6.73
Fibroblast - Pulmonary Artery, donor1	11250-116E8	49.63	9.40
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	41.65	7.72
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	11.36	7.35
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	15.02	5.14
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	47.23	9.13
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	37.12	5.15
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	34.29	4.73
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	28.88	4.81
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	32.28	6.48
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	36.95	8.35
Fibroblast - skin normal, donor1	11553-120C5	39.05	6.89
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	35.09	7.42
Fibroblast - skin normal, donor2	11561-120D4	47.12	10.15
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	50.47	9.07
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	34.80	6.63
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	20.17	7.52
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	38.75	6.24
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	74.03	16.19
Fibroblast - skin walker warburg, donor1	11554-120C6	57.01	8.60
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	37.32	8.63
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	620.47	44.32
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	29.63	13.94
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	51.83	9.88
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	46.58	8.07
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	45.23	7.67
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	29.09	13.01
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	35.73	10.21
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	57.91	34.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	33.37	20.13
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	26.26	18.27
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	41.21	21.99
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	28.55	19.03
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	24.46	15.66
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	33.61	16.36
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	44.94	23.46
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	43.84	20.07
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	24.18	14.51
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	47.33	16.11
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	52.88	21.04
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	41.68	17.28
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	32.86	12.32
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	50.70	19.31
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	39.34	20.11
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	28.66	10.64
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	44.67	15.26
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	33.29	12.51
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	26.62	7.86
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	39.19	12.55
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	51.25	14.45
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	27.47	7.28
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	26.47	6.15
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	33.31	12.50
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	41.93	14.64
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	47.57	10.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	27.23	8.87
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	35.28	11.88
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	30.02	10.01
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	22.92	8.60
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	38.99	12.42
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	28.37	8.92
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	26.94	9.30
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	34.21	9.95
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	29.74	6.96
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	27.98	8.51
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	37.84	10.66
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	31.84	6.59
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	39.00	8.70
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	43.70	11.30
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	34.76	11.77
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	42.69	9.95
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	45.08	10.49
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	28.19	9.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	26.73	5.53
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	23.25	4.82
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	18.84	7.93
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	22.16	6.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	18.76	6.86
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	28.21	6.35
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	50.56	17.72
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	46.07	22.50
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	53.81	28.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	35.36	8.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	38.43	8.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	38.74	14.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	27.22	17.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	37.13	14.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	27.28	6.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	48.69	12.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	37.10	11.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	35.83	13.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	26.66	10.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	36.35	15.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	29.09	8.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	38.59	14.26
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	34.99	12.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	25.47	9.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	18.79	6.26
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	33.22	15.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	18.94	7.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	32.19	13.55
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	32.72	14.91
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	26.93	8.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	10.54	10.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	23.45	9.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	20.54	9.13
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	16.72	13.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	27.35	13.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	39.71	9.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	32.30	17.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	27.37	11.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	31.38	16.90
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	30.52	15.26
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	26.32	10.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	29.11	13.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	31.87	18.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	23.34	16.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	30.28	16.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	38.15	18.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	24.47	10.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	21.35	11.16
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	38.80	7.99
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	14.97	4.99
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	24.74	3.37
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	21.25	5.07
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	15.04	2.51
Hep-2 cells mock treated, biol_rep1	11898-125E8	20.89	7.77
Hep-2 cells mock treated, biol_rep2	11899-125E9	27.51	6.41
Hep-2 cells mock treated, biol_rep3	11900-125F1	23.21	7.74
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	21.53	7.11
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	22.35	8.17
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	19.16	9.26
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	20.67	6.48
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	25.39	7.38
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	22.11	4.49
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	25.74	7.83
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	9.95	4.76
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	23.79	7.93
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	20.46	6.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	6.54	4.36
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	29.72	5.59
Hepatocyte, donor1	11523-119I2	18.16	4.84
Hepatocyte, donor2	11603-120I1	21.55	8.62
Hepatocyte, donor3	11684-122I1	38.65	7.98
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	44.38	21.54
Intestinal epithelial cells (polarized), donor1	11246-116E4	88.61	26.22
Iris Pigment Epithelial Cells, donor1	11530-119I9	31.15	8.10
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	25.47	12.74
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	26.70	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	20.77	4.15
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	10.01	7.51
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	11.87
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	28.19	12.81
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	13.71	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	17.87	6.50
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	11.67	3.33
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	25.41	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	25.15	3.97
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	25.50	5.54
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	31.43	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	27.08	7.56
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	10.83	12.37
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	14.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	14.21	7.11
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	19.32	6.44
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	23.90	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	20.37	5.70
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	20.57	3.78
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	34.56	7.23
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	12.00	9.23
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	18.41	5.66
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	16.33	1.81
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	44.23	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	22.60	6.46
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	25.41	7.62
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	32.86	16.43
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	19.13	9.57
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	21.87	9.11
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	47.41	15.80
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	15.00	10.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	33.18	6.64
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	41.70	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	21.61	6.79
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	29.85	3.51
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	31.43	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	32.68	6.95
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	19.92	4.43
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	19.45	6.48
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	21.80	12.21
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	13.50	4.50
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	17.42	3.48
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	30.94	5.33
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	18.01	4.16
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	19.95	5.70
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	23.01	6.44
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	15.13	3.03
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	17.98	5.29
Keratinocyte - epidermal, donor1	11272-116H3	30.11	7.92
Keratinocyte - epidermal, donor2	11349-117G8	22.84	2.34
Keratinocyte - epidermal, donor3	11421-118F8	23.19	7.19
Keratinocyte - oral, donor1	11251-116E9	42.00	12.94
Keratocytes, donor1	11527-119I6	40.92	5.85
Keratocytes, donor2	11607-120I5	5.86	5.86
Keratocytes, donor3	11688-122I5	14.82	6.52
Krukenberg tumor cell line:HSKTC	10687-109F3	21.98	19.78
Lens Epithelial Cells, donor1	11529-119I8	43.15	9.71
Lens Epithelial Cells, donor2	11609-120I7	38.41	12.11
Lens Epithelial Cells, donor3	11690-122I7	41.57	9.38
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	56.09	8.66
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	30.42	5.02
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	43.76	9.13
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	43.02	10.75
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	22.06	5.36
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	33.10	7.12
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	32.01	5.34
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	23.26	7.33
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	33.08	8.30
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	39.16	8.31
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	29.28	7.95
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	22.22	7.41
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	36.58	8.01
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	27.19	6.92
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	32.69	6.59
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	37.57	8.93
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	20.58	6.23
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	30.38	7.87
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	36.20	9.87
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	22.26	6.44
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	29.87	6.72
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	47.04	15.03
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	29.62	7.81
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	34.97	9.54
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	39.92	9.33
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	29.94	7.96
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	31.43	7.52
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	38.52	7.57
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	30.67	7.34
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	28.42	6.57
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	36.34	8.24
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	33.08	7.28
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	29.36	8.05
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	41.83	9.63
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	27.67	9.88
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	24.47	7.97
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	40.53	8.36
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	36.52	8.83
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	37.37	10.08
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	35.91	12.44
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	25.21	7.27
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	28.32	5.91
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	39.75	6.45
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	28.75	9.80
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	26.37	5.89
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	66.95	10.77
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	22.28	4.61
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	34.31	6.27
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	24.93	11.33
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	30.69	11.51
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	28.95	5.94
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	32.16	13.96
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	30.24	8.44
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	39.23	11.21
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	40.19	10.31
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	36.87	8.33
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	40.26	12.89
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	39.55	10.18
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	37.36	10.80
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	47.28	11.25
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	37.49	8.73
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	29.29	9.17
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	25.99	9.99
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	41.77	14.77
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	31.48	10.94
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	43.27	13.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	35.59	10.43
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	39.96	8.15
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	42.90	11.66
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	42.88	18.78
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	47.40	9.27
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	40.35	10.45
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	31.39	13.15
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	36.51	8.85
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	37.12	12.73
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	32.82	11.80
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	36.84	8.06
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	39.91	13.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	34.53	19.25
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	36.92	9.03
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	41.12	13.10
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	36.63	11.49
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	31.37	8.96
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	33.07	10.78
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	32.31	10.34
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	34.25	11.99
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	40.31	10.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	28.36	8.45
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	40.53	8.53
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	29.22	13.75
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	31.13	9.12
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	25.59	5.39
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	33.34	11.11
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	33.72	13.96
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	20.10	7.40
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	34.01	12.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	33.44	12.36
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	39.09	6.90
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	38.48	11.35
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	31.99	9.41
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	46.26	10.06
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	39.65	15.32
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	51.63	15.49
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	38.30	12.02
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	29.72	10.17
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	41.56	11.88
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	42.55	10.38
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	45.94	14.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	38.58	14.54
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	32.24	14.57
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	39.34	11.96
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	42.53	15.70
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	47.10	12.50
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	37.37	13.12
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	43.14	18.84
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	27.67	9.68
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	44.84	11.78
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	37.70	15.49
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	33.26	10.88
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	42.15	11.41
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	46.38	16.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	35.63	12.64
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	43.20	11.31
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	48.81	17.68
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	27.81	13.05
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	39.52	12.06
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	34.45	20.36
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	35.07	15.45
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	42.75	7.90
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	33.45	14.05
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	33.68	6.95
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	45.26	15.36
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	49.56	14.68
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	28.45	16.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	41.60	12.54
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	37.58	15.34
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	32.28	10.40
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	36.08	9.35
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	46.01	15.08
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	41.11	9.28
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	35.34	20.79
Macrophage - monocyte derived, donor1	11232-116C8	193.50	37.15
Macrophage - monocyte derived, donor2	11313-117C8	147.17	26.98
Macrophage - monocyte derived, donor3	11389-118C3	120.86	31.85
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	54.70	10.62
Mallassez-derived cells, donor2	11929-125I3	50.07	9.82
Mallassez-derived cells, donor3	11930-125I4	56.57	7.51
Mammary Epithelial Cell, donor1	11273-116H4	48.73	10.46
Mammary Epithelial Cell, donor2	11350-117G9	50.96	8.11
Mammary Epithelial Cell, donor3	11422-118F9	19.46	4.99
Mast cell - stimulated, donor1	11487-119E2	80.67	18.98
Mast cell, donor1	11563-120D6	78.40	13.19
Mast cell, donor2	11565-120D8	95.69	28.83
Mast cell, donor3	11566-120D9	86.00	24.54
Mast cell, donor4	11567-120E1	58.51	17.91
Mast cell, expanded and stimulated, donor5	11940-126A5	82.50	22.51
Mast cell, expanded and stimulated, donor8	11942-126A7	67.12	22.76
Mast cell, expanded, donor5	11939-126A4	88.57	19.16
Mast cell, expanded, donor8	11941-126A6	80.50	17.07
Melanocyte - dark, donor1	11502-119F8	28.26	5.17
Melanocyte - dark, donor2	11582-120F7	19.73	5.54
Melanocyte - dark, donor3	11663-122F7	81.13	9.71
Melanocyte - light, donor1	11274-116H5	56.89	7.99
Melanocyte - light, donor2	11351-117H1	53.23	4.09
Melanocyte - light, donor3	11423-118G1	34.69	6.07
Melanocyte, donor1 (MC+1)	12641-134G4	47.27	13.54
Melanocyte, donor2 (MC+2)	12739-135I3	50.83	10.22
Melanocyte, donor3 (MC+3)	12837-137B2	44.46	6.16
Meningeal Cells, donor1	11493-119E8	50.99	12.03
Meningeal Cells, donor2	11573-120E7	35.65	10.12
Meningeal Cells, donor3	11654-122E7	45.56	10.11
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	26.80	6.27
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	34.21	7.04
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	5.26	1.31
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	10.47	2.62
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	20.09	7.89
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	53.58	6.99
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	44.74	12.57
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	32.96	5.71
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	18.26	14.61
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	16.78	8.59
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	22.58	6.65
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	8.18	1.49
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	25.13	5.92
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	7.72	0.59
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	9.34	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	12.81	10.25
Mesenchymal stem cells - adipose, donor0	11217-116B2	45.01	6.03
Mesenchymal stem cells - hepatic, donor0	11218-116B3	29.40	7.51
Mesenchymal stem cells - umbilical, donor0	11214-116A8	25.40	2.90
Mesothelial Cells, donor1	11247-116E5	47.47	10.87
Mesothelial Cells, donor2	12156-128G5	27.03	5.00
Mesothelial Cells, donor3	11402-118D7	20.67	10.98
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	48.61	10.80
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	117.72	46.55
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	92.46	36.22
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	31.11	17.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	106.93	40.91
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	80.69	25.10
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	20.84	9.26
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	102.36	30.03
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	91.23	34.91
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	19.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	86.37	32.92
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	95.43	34.05
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	17.10
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	101.77	23.89
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	94.98	26.22
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	17.11	23.69
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	78.74	23.77
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	36.83	26.70
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	75.71	27.42
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	18.44	31.86
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	87.57	27.85
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	66.55	25.67
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	26.54	29.30
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	99.93	23.02
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	90.87	31.13
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	67.26	24.66
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	93.11	21.24
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	72.91	27.79
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	30.96
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	74.90	25.19
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	52.72	28.90
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	19.88	18.23
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	78.28	24.19
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	67.64	32.35
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	23.99	20.72
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	90.82	20.18
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	85.25	32.42
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	32.91	30.17
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	88.60	26.03
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	53.89	26.95
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	22.42	28.54
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	74.45	25.84
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	29.80	25.38
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	37.78	30.74
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	96.19	24.30
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	46.63	22.96
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	28.73	26.52
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	83.08	18.80
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	59.52	28.01
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	55.04	25.57
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	82.48	22.16
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	77.72	35.74
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	25.64	20.40
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	68.18	18.40
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	96.00	28.38
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	21.66
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	70.19	26.78
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	93.34	34.72
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	73.10	25.01
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	76.45	18.66
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	84.08	32.60
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	29.22	16.51
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	52.58	16.55
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	97.58	24.55
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	54.81	19.92
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	76.12	20.07
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	97.30	29.41
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	42.09	22.75
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	78.70	25.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	102.25	19.91
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	39.75	20.85
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	64.69	19.11
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	79.29	27.10
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	61.00	14.01
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	61.34	23.52
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	131.84	11.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	98.02	23.17
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	129.13	21.03
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	105.20	24.19
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	148.86	24.71
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	107.10	33.53
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	122.05	28.16
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	103.61	20.51
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	180.40	27.82
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	77.36	19.89
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	104.43	21.99
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	91.78	14.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	112.23	17.64
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	108.19	19.32
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	140.38	21.21
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	75.90	22.35
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	73.54	9.53
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	32.43	7.63
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	32.39	3.24
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	51.35	10.57
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	131.33	22.84
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	182.70	39.15
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	109.31	42.77
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	50.20	75.29
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	79.50	12.93
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	33.97	13.59
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	10.01	4.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	22.54	6.26
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	79.10	18.44
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	15.96	27.13
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	6.80	4.76
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	147.01	25.73
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	9.21	1.67
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	41.61	12.32
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	14.86	3.78
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	24.18	7.99
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	155.89	44.54
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	13.90	2.48
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	24.09	3.79
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	17.91	5.21
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	12.41	4.57
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	22.78	7.11
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	13.79	2.12
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	9.60	2.40
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	52.84	11.49
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	13.66	3.42
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	20.64	6.17
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	14.77	4.22
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	11.03	2.30
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	10.60	3.86
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	70.70	16.55
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	128.95	48.04
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	18.27	4.46
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	17.36	6.35
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	20.65	5.46
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	16.74	4.29
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	225.69	27.08
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	10.00	4.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	14.88	5.86
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	14.28	8.33
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	12.07	4.64
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	23.84	6.05
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	14.34	2.28
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	11.33	3.49
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	17.64	9.50
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	9.70	1.76
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	9.31	3.32
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	9.92	1.98
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	7.27	3.45
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	17.24	7.56
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	19.23	6.19
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	8.13	4.07
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	102.19	20.44
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	6.71	3.05
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	11.02	3.78
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	6.96	3.03
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	15.82	3.96
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	54.41	19.27
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	85.98	10.12
Myoblast, donor1	11241-116D8	78.76	11.80
Myoblast, donor2	11322-117D8	45.84	10.74
Myoblast, donor3	11398-118D3	61.38	14.80
NK T cell leukemia cell line:KHYG-1	10777-110G3	63.04	12.99
Natural Killer Cells, donor1	11230-116C6	84.26	10.76
Natural Killer Cells, donor2	11311-117C6	60.01	14.47
Natural Killer Cells, donor3	11387-118C1	69.76	14.72
Neural stem cells, donor1	11275-116H6	58.43	29.76
Neural stem cells, donor2	11352-117H2	40.44	15.41
Neurons, donor1	11494-119E9	30.72	21.62
Neurons, donor2	11574-120E8	33.91	19.37
Neurons, donor3	11655-122E8	18.09	12.33
Neutrophils, donor1	11233-116C9	116.93	37.12
Neutrophils, donor2	11314-117C9	78.27	34.79
Neutrophils, donor3	11390-118C4	156.99	48.26
Nucleus Pulposus Cell, donor1	11252-116F1	18.88	4.16
Nucleus Pulposus Cell, donor2	11409-118E5	7.81	3.26
Nucleus Pulposus Cell, donor3	11462-119B4	15.04	6.62
Olfactory epithelial cells, donor1	11933-125I7	15.42	4.82
Olfactory epithelial cells, donor2	11934-125I8	27.65	8.97
Olfactory epithelial cells, donor3	11935-125I9	18.39	6.36
Olfactory epithelial cells, donor4	11936-126A1	21.14	6.62
Oligodendrocyte - precursors, donor1	11496-119F2	45.74	10.83
Osteoblast - differentiated, donor1	11276-116H7	15.31	3.62
Osteoblast - differentiated, donor2	11353-117H3	9.14	3.43
Osteoblast - differentiated, donor3	11425-118G3	6.21	3.10
Osteoblast, donor1	11277-116H8	24.04	5.67
Osteoblast, donor2	11354-117H4	49.16	5.62
Osteoblast, donor3	11426-118G4	23.10	5.87
Pancreatic stromal cells, donor1	11249-116E7	30.91	6.32
Pericytes, donor1	11491-119E6	8.12	2.78
Pericytes, donor2	11571-120E5	9.28	7.92
Pericytes, donor3	11652-122E5	21.77	7.93
Perineurial Cells, donor1	11499-119F5	36.17	8.36
Perineurial Cells, donor2	11579-120F4	22.08	4.51
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	91.48	18.81
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	78.36	21.06
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	68.72	14.75
Placental Epithelial Cells, donor1	11278-116H9	20.33	5.26
Placental Epithelial Cells, donor2	11355-117H5	22.18	1.11
Placental Epithelial Cells, donor3	11427-118G5	7.26	2.36
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	21.84	4.75
Preadipocyte - breast, donor1	11467-119B9	33.58	5.82
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	31.72	6.53
Preadipocyte - breast, donor2	11328-117E5	30.85	6.30
Preadipocyte - omental, donor1	11468-119C1	29.94	9.27
Preadipocyte - omental, donor2	11329-117E6	37.10	10.48
Preadipocyte - omental, donor3	11403-118D8	31.08	7.88
Preadipocyte - perirenal, donor1	11469-119C2	30.51	5.91
Preadipocyte - subcutaneous, donor1	11279-116I1	33.17	4.91
Preadipocyte - subcutaneous, donor2	11356-117H6	28.51	10.27
Preadipocyte - subcutaneous, donor3	11428-118G6	19.41	4.60
Preadipocyte - visceral, donor1	11280-116I2	35.68	7.92
Preadipocyte - visceral, donor2	11357-117H7	23.01	15.19
Preadipocyte - visceral, donor3	11429-118G7	24.97	6.79
Prostate Epithelial Cells (polarized), donor1	11253-116F2	71.96	22.33
Prostate Epithelial Cells, donor2	11331-117E8	31.28	8.12
Prostate Epithelial Cells, donor3	11404-118D9	38.95	9.98
Prostate Stromal Cells, donor1	11254-116F3	42.83	7.06
Prostate Stromal Cells, donor2	11332-117E9	29.05	6.99
Prostate Stromal Cells, donor3	11405-118E1	20.23	3.86
Renal Cortical Epithelial Cells, donor1	11516-119H4	35.77	8.76
Renal Cortical Epithelial Cells, donor2	11596-120H3	60.44	12.89
Renal Epithelial Cells, donor1	11517-119H5	18.26	3.55
Renal Epithelial Cells, donor2	11597-120H4	14.23	5.69
Renal Epithelial Cells, donor3	11678-122H4	51.24	10.48
Renal Glomerular Endothelial Cells, donor1	11514-119H2	10.21	2.04
Renal Glomerular Endothelial Cells, donor2	11594-120H1	27.22	9.84
Renal Glomerular Endothelial Cells, donor3	11675-122H1	47.07	11.54
Renal Glomerular Endothelial Cells, donor4	11783-124B1	10.65	2.00
Renal Mesangial Cells, donor1	11518-119H6	23.33	4.40
Renal Mesangial Cells, donor2	11598-120H5	18.18	11.91
Renal Mesangial Cells, donor3	11679-122H5	9.43	2.77
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	72.21	10.74
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	41.75	8.01
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	25.07	9.45
Retinal Pigment Epithelial Cells, donor0	11215-116A9	73.90	19.45
Retinal Pigment Epithelial Cells, donor1	11528-119I7	34.39	9.10
Retinal Pigment Epithelial Cells, donor2	11608-120I6	11.32	7.20
Retinal Pigment Epithelial Cells, donor3	11689-122I6	38.64	9.53
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	46.77	12.29
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	15.19	2.68
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	38.53	5.50
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	21.46	8.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	21.84	5.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	17.48	6.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	31.57	6.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	30.51	6.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	15.73	6.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	27.97	8.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	17.80	4.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	17.09	5.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	24.73	6.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	18.36	3.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	19.21	4.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	22.57	9.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	14.34	4.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	17.79	6.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	25.74	6.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	18.05	5.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	16.26	4.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	26.35	6.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	15.81	3.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	16.26	4.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	18.97	5.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	16.05	4.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	13.86	5.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	20.82	7.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	20.99	2.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	17.06	6.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	18.71	7.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	18.66	3.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	18.58	6.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	18.38	6.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	17.90	3.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	15.16	6.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	21.40	8.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	25.45	4.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	19.34	6.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	25.94	7.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	15.68	3.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	16.87	6.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	18.66	6.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	16.59	5.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	17.86	4.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	18.94	4.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	15.35	2.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	18.17	6.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	18.74	5.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	16.64	1.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	41.48	7.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	24.34	6.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	19.29	3.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	17.42	6.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	24.56	5.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	21.96	4.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	18.36	4.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	17.43	6.61
Schwann Cells, donor1	11498-119F4	11.28	3.39
Schwann Cells, donor2	11578-120F3	20.41	3.40
Schwann Cells, donor3	11659-122F3	23.88	8.76
Sebocyte, donor1	11220-116B5	41.63	5.48
Sebocyte, donor2	11301-117B5	21.60	6.89
Sebocyte, donor3	11378-118B1	26.59	5.77
Sertoli Cells, donor1	11255-116F4	48.04	16.57
Sertoli Cells, donor2	11333-117F1	28.24	5.65
Skeletal Muscle Cells, donor1	11281-116I3	24.72	4.75
Skeletal Muscle Cells, donor2	11358-117H8	7.95	2.89
Skeletal Muscle Cells, donor3	11430-118G8	18.39	10.03
Skeletal Muscle Cells, donor4	11451-119A2	23.72	6.91
Skeletal Muscle Cells, donor5	11455-119A6	19.47	6.24
Skeletal Muscle Cells, donor6	11459-119B1	27.39	12.16
Skeletal Muscle Satellite Cells, donor1	11240-116D7	23.19	7.31
Skeletal Muscle Satellite Cells, donor2	11321-117D7	14.70	6.99
Skeletal Muscle Satellite Cells, donor3	11397-118D2	30.66	9.33
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	21.91	4.89
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	10.86	5.79
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	13.48	5.78
Skin - palm, donor1	10286-104F7	32.23	21.49
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	21.05	6.34
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	62.16	13.90
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	22.46	5.06
Small Airway Epithelial Cells, donor1	11256-116F5	43.93	8.34
Small Airway Epithelial Cells, donor2	11334-117F2	24.19	6.05
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	57.09	9.52
Small Airway Epithelial Cells, donor3	11406-118E2	24.58	8.02
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	32.40	3.09
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	30.24	5.78
Smooth Muscle Cells - Aortic, donor0	11210-116A4	29.39	8.82
Smooth Muscle Cells - Aortic, donor1	11283-116I5	35.80	4.64
Smooth Muscle Cells - Aortic, donor2	11360-117I1	57.10	8.27
Smooth Muscle Cells - Aortic, donor3	11432-118H1	30.90	6.18
Smooth Muscle Cells - Bladder, donor1	11519-119H7	13.01	2.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	46.04	10.78
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	29.92	6.87
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	47.12	20.10
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	41.02	12.05
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	40.46	8.56
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	28.90	6.83
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	10.74	5.21
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	20.09	3.65
Smooth Muscle Cells - Carotid, donor1	11285-116I7	22.73	5.05
Smooth Muscle Cells - Carotid, donor2	11362-117I3	24.48	6.12
Smooth Muscle Cells - Carotid, donor3	11434-118H3	22.41	5.25
Smooth Muscle Cells - Colonic, donor1	11239-116D6	26.84	5.90
Smooth Muscle Cells - Colonic, donor2	11320-117D6	20.88	4.95
Smooth Muscle Cells - Colonic, donor3	11396-118D1	26.55	7.98
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	47.33	10.83
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	37.73	16.17
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	31.68	11.95
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	6.83	2.05
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	17.98	5.10
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	49.31	9.56
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	38.00	8.65
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	27.17	7.85
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	53.25	14.57
Smooth Muscle Cells - Prostate, donor1	11257-116F6	33.16	8.66
Smooth Muscle Cells - Prostate, donor2	11335-117F3	18.16	5.38
Smooth Muscle Cells - Prostate, donor3	11465-119B7	18.26	6.85
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	55.33	11.01
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	16.50	3.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	12.92	3.88
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	32.55	6.05
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	35.34	4.04
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	38.55	8.46
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	10.62	2.65
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	26.74	5.50
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	7.01	1.87
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	58.29	7.77
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	41.30	6.37
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	27.45	8.65
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	32.42	6.99
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	29.74	4.69
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	6.19	3.81
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	54.31	8.81
Smooth Muscle Cells - Uterine, donor1	11258-116F7	36.68	7.07
Smooth Muscle Cells - Uterine, donor3	11466-119B8	25.75	5.56
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	18.08	5.25
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	29.62	7.40
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	39.05	7.81
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	34.86	10.06
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	67.85	13.34
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	42.93	9.85
Smooth muscle cells - airway, control, donor1	11966-126D4	21.84	3.30
Smooth muscle cells - airway, control, donor2	11967-126D5	14.38	3.59
Smooth muscle cells - airway, control, donor3	11968-126D6	14.21	5.02
Smooth muscle cells - airway, control, donor4	11969-126D7	9.63	4.13
Synoviocyte, donor1	11291-117A4	31.31	6.56
Synoviocyte, donor2	11368-117I9	19.61	4.69
Synoviocyte, donor3	11440-118H9	13.63	5.36
Trabecular Meshwork Cells, donor1	11532-120A2	21.80	3.93
Trabecular Meshwork Cells, donor2	11612-122A1	5.95	1.98
Trabecular Meshwork Cells, donor3	11693-123A1	6.71	4.17
Tracheal Epithelial Cells, donor1	11292-117A5	35.77	7.24
Tracheal Epithelial Cells, donor2	11369-118A1	18.94	6.96
Tracheal Epithelial Cells, donor3	11441-118I1	18.33	9.74
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	49.58	13.78
Urethra, donor2	10319-105A4	19.78	28.77
Urothelial Cells, donor1	11520-119H8	17.80	2.39
Urothelial Cells, donor2	11600-120H7	17.62	6.41
Urothelial Cells, donor3	11681-122H7	8.71	5.73
Urothelial cells, donor0	11216-116B1	41.01	6.24
Whole blood (ribopure), donor090309, donation1	12179-129A1	118.34	26.69
Whole blood (ribopure), donor090309, donation2	12180-129A2	128.67	34.31
Whole blood (ribopure), donor090309, donation3	12181-129A3	49.29	19.17
Whole blood (ribopure), donor090325, donation1	12176-128I7	66.80	18.25
Whole blood (ribopure), donor090325, donation2	12177-128I8	79.60	24.98
Whole blood (ribopure), donor090612, donation1	12182-129A4	98.92	18.74
Whole blood (ribopure), donor090612, donation2	12183-129A5	109.22	31.20
Whole blood (ribopure), donor090612, donation3	12184-129A6	43.82	17.35
Wilms' tumor cell line:G-401	10809-111A8	21.96	7.15
Wilms' tumor cell line:HFWT	10597-108E3	14.96	7.92
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	35.75	10.61
achilles tendon, donor2	10292-104G4	70.26	20.67
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	23.20	5.35
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	40.40	13.93
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	33.00	15.67
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	87.89	23.67
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	49.47	16.30
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	79.09	15.23
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	45.73	12.25
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	53.32	20.71
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	54.31	22.46
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	47.37	19.41
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	59.43	13.62
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	50.71	27.30
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	52.98	14.41
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	52.30	12.17
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	49.10	15.78
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	26.96	13.01
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	59.63	15.22
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	36.83	15.04
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	50.35	15.36
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	52.77	13.95
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	56.57	18.29
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	73.06	19.82
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	39.69	14.68
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	11.15	5.57
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	62.15	16.95
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	44.92	17.01
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	26.24	15.00
adenocarcinoma cell line:IM95m	10796-110I4	50.87	21.43
adipose tissue, adult, pool1	10010-101C1	37.54	10.39
adipose, donor1	10184-103D4	44.57	26.97
adipose, donor2	10185-103D5	12.98	16.22
adipose, donor3	10186-103D6	22.06	13.61
adipose, donor4	10187-103D7	30.34	8.67
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	23.83	18.62
adrenal gland, adult, pool1	10081-102A9	50.93	14.55
adult T-cell leukemia cell line:ATN-1	10421-106C7	74.31	17.61
alveolar cell carcinoma cell line:SW 1573	10708-109H6	34.30	10.72
amniotic membrane cells, donor1	12235-129G3	35.47	9.04
amniotic membrane cells, donor2	12236-129G4	19.95	6.42
amniotic membrane cells, donor3	12237-129G5	16.79	10.90
amygdala - adult, donor10196	10167-103B5	139.92	37.95
amygdala, adult, donor10252	10151-102I7	81.51	37.11
amygdala, newborn, donor10223	10360-105E9	67.46	32.60
anaplastic carcinoma cell line:8305C	10428-106D5	33.11	8.79
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	69.28	13.24
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	49.44	14.36
aorta, adult, pool1	10052-101G7	22.36	11.96
appendix, adult	10189-103D9	37.65	17.47
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	36.11	11.35
artery, adult	10190-103E1	8.15	14.95
astrocytoma cell line:TM-31	10425-106D2	42.45	10.87
b cell line:RPMI1788	10427-106D4	31.67	8.92
basal cell carcinoma cell line:TE 354.T	10702-109G9	77.96	12.49
bile duct carcinoma cell line:HuCCT1	10432-106D9	42.17	6.05
bile duct carcinoma cell line:TFK-1	10496-107C1	62.60	10.71
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	44.74	11.18
bladder, adult, pool1	10011-101C2	21.73	8.69
blood, adult, pool1	10053-101G8	55.37	26.58
bone marrow stromal cell line:StromaNKtert	10686-109F2	23.12	2.57
bone marrow, adult	10192-103E3	39.81	20.24
brain, adult, donor1	10084-102B3	75.86	39.98
brain, adult, pool1	10012-101C3	102.56	38.53
brain, fetal, pool1	10085-102B4	53.43	13.36
breast carcinoma cell line:MCF7	10482-107A5	34.03	18.83
breast carcinoma cell line:MDA-MB-453	10419-106C5	23.34	8.11
breast, adult, donor1	10080-102A8	30.94	12.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	27.95	16.26
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	48.24	18.55
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	34.07	17.27
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	23.72	11.38
carcinoid cell line:NCI-H1770	10703-109H1	10.81	3.76
carcinoid cell line:NCI-H727	10735-110B6	37.19	14.99
carcinoid cell line:SK-PN-DW	10719-109I8	19.96	10.14
carcinosarcoma cell line:JHUCS-1	10642-109A3	23.69	14.37
caudate nucleus - adult, donor10196	10177-103C6	149.67	55.26
caudate nucleus, adult, donor10252	10164-103B2	94.71	45.51
caudate nucleus, adult, donor10258	10379-105H1	100.87	51.20
caudate nucleus, newborn, donor10223	10354-105E3	82.40	66.29
cerebellum - adult, donor10196	10173-103C2	122.36	43.70
cerebellum, adult, donor10252	10166-103B4	81.13	33.73
cerebellum, adult, pool1	10083-102B2	67.26	27.60
cerebellum, newborn, donor10223	10357-105E6	106.28	53.97
cerebral meninges, adult	10188-103D8	89.26	63.54
cerebrospinal fluid, donor2	10294-104G6	43.12	26.31
cervical cancer cell line:D98-AH2	10552-107I3	40.83	5.90
cervical cancer cell line:ME-180	10553-107I4	37.29	4.97
cervix, adult, pool1	10013-101C4	19.84	10.39
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	37.06	5.29
chondrosarcoma cell line:SW 1353	10700-109G7	19.59	14.37
choriocarcinoma cell line:BeWo	10423-106C9	33.68	11.18
choriocarcinoma cell line:SCH	10785-110H2	30.06	9.49
choriocarcinoma cell line:T3M-3	10618-108G6	36.76	7.35
chorionic membrane cells, donor1	12238-129G6	45.59	13.11
chorionic membrane cells, donor2	12239-129G7	54.59	10.94
chorionic membrane cells, donor3	12240-129G8	28.57	19.23
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	20.20	5.05
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	50.91	15.18
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	39.70	12.25
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	32.61	8.47
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	26.61	8.95
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	27.69	7.94
chronic myelogenous leukemia cell line:K562	10454-106G4	30.33	11.78
chronic myelogenous leukemia cell line:KU812	10409-106B4	37.79	6.52
clear cell carcinoma cell line:JHOC-5	10638-108I8	80.00	30.63
clear cell carcinoma cell line:TEN	10636-108I6	41.12	6.94
colon carcinoma cell line:CACO-2	10513-107D9	87.13	30.75
colon carcinoma cell line:COLO-320	10420-106C6	14.82	5.32
colon, adult, donor1	10082-102B1	58.31	9.52
colon, adult, pool1	10014-101C5	39.60	10.11
colon, fetal, donor1	10070-101I7	40.79	16.07
common myeloid progenitor CMP, donor1	12130-128D6	73.34	22.92
common myeloid progenitor CMP, donor2	12134-128E1	25.04	25.04
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	45.47	7.65
cord blood derived cell line:COBL-a 24h infection	10453-106G3	29.43	6.19
cord blood derived cell line:COBL-a untreated	10449-106F8	25.81	6.35
corpus callosum, adult, pool1	10042-101F6	81.71	51.30
cruciate ligament, donor2	10295-104G7	44.58	17.83
diaphragm, fetal, donor1	10069-101I6	15.25	6.42
diencephalon, adult	10193-103E4	84.48	40.32
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	30.54	5.74
ductal cell carcinoma cell line:KLM-1	10438-106E6	38.21	9.74
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	45.98	14.68
ductus deferens, adult	10196-103E7	31.40	22.92
duodenum, fetal, donor1, tech_rep1	10071-101I8	37.45	14.40
duodenum, fetal, donor1, tech_rep2	10071-101I8	50.76	19.86
dura mater, adult, donor1	10041-101F5	46.83	17.84
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	31.31	4.66
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	32.24	11.03
embryonic pancreas cell line:1B2C6	10604-108F1	27.75	20.35
embryonic pancreas cell line:1C3D3	10605-108F2	28.76	13.02
embryonic pancreas cell line:1C3IKEI	10606-108F3	31.18	8.34
embryonic pancreas cell line:2C6	10603-108E9	21.02	14.45
endometrial carcinoma cell line:OMC-2	10497-107C2	39.22	20.78
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	44.58	12.51
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	78.64	16.56
epidermoid carcinoma cell line:A431	10426-106D3	32.79	7.45
epidermoid carcinoma cell line:Ca Ski	10431-106D8	33.11	6.49
epididymis, adult	10197-103E8	39.98	15.70
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	16.14	7.63
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	18.88	6.69
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	30.40	9.44
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	19.68	6.20
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	26.44	8.51
esophagus, adult, pool1	10015-101C6	25.38	8.71
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	25.92	8.64
eye - muscle inferior rectus, donor1	10272-104E2	45.88	38.63
eye - muscle lateral, donor2	10298-104H1	39.98	25.25
eye - muscle medial, donor2	10299-104H2	80.36	41.67
eye - muscle superior, donor2	10297-104G9	47.01	35.54
eye - vitreous humor, donor1	10268-104D7	30.61	30.61
eye, fetal, donor1	10054-101G9	39.91	20.08
fibrosarcoma cell line:HT-1080	10758-110E2	32.06	7.44
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	42.26	18.99
frontal lobe, adult, pool1	10040-101F4	142.61	48.60
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	41.13	10.81
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	33.28	11.89
gall bladder, adult	10198-103E9	27.52	14.24
gamma delta positive T cells, donor1	11937-126A2	54.76	12.88
gamma delta positive T cells, donor2	11938-126A3	54.16	13.07
gastric adenocarcinoma cell line:MKN1	10614-108G2	60.41	8.87
gastric adenocarcinoma cell line:MKN45	10612-108F9	39.46	14.89
gastric cancer cell line:AZ521	10549-107H9	25.58	6.56
gastric cancer cell line:GSS	10560-108A2	18.30	13.73
gastrointestinal carcinoma cell line:ECC12	10615-108G3	26.04	12.79
giant cell carcinoma cell line:LU65	10487-107B1	43.03	7.57
giant cell carcinoma cell line:Lu99B	10433-106E1	45.49	10.78
glassy cell carcinoma cell line:HOKUG	10688-109F4	36.42	10.48
glioblastoma cell line:A172, tech_rep1	10444-106F3	32.19	8.55
glioblastoma cell line:A172, tech_rep2	10444-106F3	30.62	7.02
glioblastoma cell line:T98G	10485-107A8	22.41	6.62
glioma cell line:GI-1	10413-106B8	18.16	3.81
globus pallidus - adult, donor10196	10175-103C4	78.72	74.35
globus pallidus, adult, donor10252	10161-103A8	70.79	42.96
globus pallidus, adult, donor10258	10367-105F7	93.11	62.98
globus pallidus, newborn, donor10223	10364-105F4	55.42	41.57
granulocyte macrophage progenitor, donor1	12131-128D7	78.31	26.92
granulocyte macrophage progenitor, donor2	12135-128E2	76.50	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	36.59	10.45
granulosa cell tumor cell line:KGN	10624-108H3	40.00	10.24
hIPS +CCl2, biol_rep1	14383-156B9	33.52	20.66
hIPS +CCl2, biol_rep2	14384-156C1	38.87	18.75
hIPS +CCl2, biol_rep3	14385-156C2	36.07	14.81
hIPS, biol_rep1	14380-156B6	63.24	5.75
hIPS, biol_rep2	14381-156B7	37.04	9.60
hIPS, biol_rep3	14382-156B8	109.24	52.97
hairy cell leukemia cell line:Mo	10712-109I1	48.27	15.52
heart - mitral valve, adult	10205-103F7	20.93	17.64
heart - pulmonic valve, adult	10206-103F8	15.95	13.60
heart - tricuspid valve, adult	10207-103F9	32.47	9.16
heart, adult, diseased post-infarction, donor1	10050-101G5	33.47	8.57
heart, adult, diseased, donor1	10051-101G6	45.14	20.87
heart, adult, pool1	10016-101C7	23.23	9.43
heart, fetal, pool1	10046-101G1	38.40	21.36
hepatic mesenchymal tumor cell line:LI90	10778-110G4	27.77	9.26
hepatoblastoma cell line:HuH-6	10633-108I3	17.84	15.46
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	55.47	17.79
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	57.90	22.45
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	54.37	21.73
hepatoma cell line:Li-7	10484-107A7	37.92	6.45
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	30.55	5.83
hippocampus - adult, donor10196	10169-103B7	181.69	61.51
hippocampus, adult, donor10252	10153-102I9	72.66	30.00
hippocampus, adult, donor10258	10374-105G5	124.99	26.89
hippocampus, newborn, donor10223	10363-105F3	73.32	43.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	82.40	31.13
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	34.36	18.06
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	42.91	22.85
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	29.88	12.97
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	24.01	14.72
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	29.61	19.36
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	30.07	24.52
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	35.76	23.48
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	27.53	24.61
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	42.62	14.92
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	27.80	10.13
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	35.01	9.43
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	26.29	12.05
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	31.93	12.28
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	50.62	16.58
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	16.99	12.98
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	18.32	6.11
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	25.99	16.99
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	26.94	16.39
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	22.28	20.01
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	24.75	16.60
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	24.99	8.33
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	21.19	7.55
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	19.13	9.86
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	37.69	16.07
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	31.95	17.40
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	53.49	25.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	24.65	13.73
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	18.69	11.40
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	17.85	17.85
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	26.89	15.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	28.56	21.25
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	17.96	17.44
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	29.40	13.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	25.75	14.39
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	29.91	13.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	30.91	14.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	39.66	23.17
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	31.71	20.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	21.70	10.39
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	214.71	61.81
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	38.39	23.50
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	30.10	15.87
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	24.25	16.65
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	28.11	13.88
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	27.45	14.32
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	46.45	15.44
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	25.86	12.66
immature langerhans cells, donor1	11904-125F5	116.96	29.30
immature langerhans cells, donor2	11905-125F6	79.21	43.57
insula, adult, pool1	10039-101F3	157.94	52.81
keratoacanthoma cell line:HKA-1	10791-110H8	33.17	10.40
kidney, adult, pool1	10017-101C8	98.83	20.43
kidney, fetal, pool1	10045-101F9	66.99	19.88
large cell lung carcinoma cell line:IA-LM	10509-107D5	39.91	9.23
large cell lung carcinoma cell line:NCI-H460	10839-111E2	25.85	8.85
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	24.22	7.34
left atrium, adult, donor1	10079-102A7	19.07	9.81
left ventricle, adult, donor1	10078-102A6	30.34	14.66
leiomyoblastoma cell line:G-402	10721-110A1	25.17	7.93
leiomyoma cell line:10964C	10569-108B2	43.83	11.86
leiomyoma cell line:15242A	10570-108B3	55.98	13.59
leiomyoma cell line:15425	10571-108B4	45.89	8.26
leiomyosarcoma cell line:Hs 5.T	10722-110A2	12.70	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	26.14	3.14
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	65.64	12.99
liposarcoma cell line:KMLS-1	10782-110G8	35.46	8.44
liposarcoma cell line:SW 872	10726-110A6	16.94	6.34
liver, adult, pool1	10018-101C9	19.45	6.16
liver, fetal, pool1	10086-102B5	15.99	10.35
locus coeruleus - adult, donor10196	10182-103D2	106.74	50.60
locus coeruleus, adult, donor10252	10165-103B3	97.26	44.29
locus coeruleus, adult, donor10258	10375-105G6	84.08	29.06
locus coeruleus, newborn, donor10223	10362-105F2	88.75	26.50
lung adenocarcinoma cell line:A549	10499-107C4	27.82	7.61
lung adenocarcinoma cell line:PC-14	10408-106B3	13.10	1.38
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	39.02	20.17
lung, adult, pool1	10019-101D1	46.42	12.40
lung, fetal, donor1	10068-101I5	73.06	28.83
lung, right lower lobe, adult, donor1	10075-102A3	38.03	21.99
lymph node, adult, donor1	10077-102A5	41.18	8.05
lymphangiectasia cell line:DS-1	10727-110A7	22.36	4.38
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	14.64	3.77
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	48.42	5.95
mature adipocyte, donor1	12231-129F8	18.20	8.44
mature adipocyte, donor2	12232-129F9	45.45	12.66
mature adipocyte, donor3	12233-129G1	24.89	10.43
mature adipocyte, donor4	12234-129G2	18.43	4.74
maxillary sinus tumor cell line:HSQ-89	10414-106B9	26.92	9.05
medial frontal gyrus - adult, donor10196	10170-103B8	182.74	54.15
medial frontal gyrus, adult, donor10252	10150-102I6	100.96	32.00
medial frontal gyrus, adult, donor10258	10368-105F8	104.52	45.43
medial frontal gyrus, newborn, donor10223	10352-105E1	290.86	93.40
medial temporal gyrus - adult, donor10196	10183-103D3	126.90	44.04
medial temporal gyrus, adult, donor10252	10156-103A3	89.13	41.60
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	275.46	40.45
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	488.02	71.77
medial temporal gyrus, newborn, donor10223	10353-105E2	117.73	50.97
medulla oblongata - adult, donor10196	10174-103C3	99.94	43.48
medulla oblongata, adult, donor10252	10155-103A2	81.58	32.66
medulla oblongata, adult, pool1	10038-101F2	110.85	40.41
medulla oblongata, newborn, donor10223	10361-105F1	47.22	30.20
medulloblastoma cell line:D283 Med	10838-111E1	29.23	10.85
medulloblastoma cell line:ONS-76	10759-110E3	27.39	10.64
melanoma cell line:COLO 679	10514-107E1	47.72	8.48
melanoma cell line:G-361	10465-106H6	49.95	5.70
meningioma cell line:HKBMM	10691-109F7	26.77	9.23
merkel cell carcinoma cell line:MKL-1	10843-111E6	18.50	10.57
merkel cell carcinoma cell line:MS-1	10844-111E7	48.47	20.48
mesenchymal precursor cell - adipose, donor1	11747-123G1	24.86	6.60
mesenchymal precursor cell - adipose, donor2	11748-123G2	11.09	4.73
mesenchymal precursor cell - adipose, donor3	11749-123G3	16.56	7.04
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	24.16	4.64
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	18.10	4.04
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	20.82	4.16
mesenchymal precursor cell - cardiac, donor1	11752-123G6	32.61	8.24
mesenchymal precursor cell - cardiac, donor2	11753-123G7	21.05	6.21
mesenchymal precursor cell - cardiac, donor3	11754-123G8	22.95	6.50
mesenchymal precursor cell - cardiac, donor4	11755-123G9	41.05	9.99
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	44.39	10.53
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	43.80	11.53
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	33.76	8.86
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	33.16	10.12
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	28.58	6.53
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	35.95	7.91
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	17.48	5.48
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	27.13	5.70
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	60.84	17.20
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	36.31	7.62
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	33.09	7.35
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	39.39	10.31
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	34.05	7.73
mesenchymal stem cell line:Hu5/E18	10568-108B1	53.05	21.05
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	17.35	4.57
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	19.95	3.07
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	15.71	7.33
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	17.56	4.93
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	19.30	4.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	17.94	6.43
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	16.11	5.50
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	16.68	4.17
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	19.61	6.06
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	18.52	4.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	19.23	5.53
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	13.93	5.13
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	17.45	2.35
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	12.28	2.46
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	15.89	3.01
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	13.67	8.20
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	17.86	4.22
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	11.64	4.36
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	19.72	5.33
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	13.08	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	16.33	1.94
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	10.49	6.30
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	13.91	5.96
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	0.00	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	13.64	5.34
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	14.62	4.87
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	15.20	5.07
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	14.14	6.21
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	15.04	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	3.99	7.98
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	10.33	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	8.96	1.63
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	3.97	1.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	7.66	3.54
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	7.48	0.94
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	10.69	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	4.73	3.55
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	12.84	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	11.01	2.07
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	11.88	1.98
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	19.07	5.61
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	8.90	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	16.12	4.03
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	26.17	6.54
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	22.81	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	29.74	9.71
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	18.08	13.56
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	22.24	9.88
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	8.73	2.38
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	7.46	4.22
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	3.06	5.09
mesodermal tumor cell line:HIRS-BM	10696-109G3	24.76	9.28
mesothelioma cell line:ACC-MESO-1	10493-107B7	36.14	12.52
mesothelioma cell line:ACC-MESO-4	10494-107B8	23.63	7.88
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	38.46	4.27
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	50.04	6.37
mesothelioma cell line:Mero-25	10850-111F4	12.03	3.18
mesothelioma cell line:Mero-41	10851-111F5	34.47	9.05
mesothelioma cell line:Mero-48a	10852-111F6	33.66	4.87
mesothelioma cell line:Mero-82	10853-111F7	42.57	7.10
mesothelioma cell line:Mero-83	10854-111F8	31.49	5.45
mesothelioma cell line:Mero-84	10855-111F9	47.77	12.64
mesothelioma cell line:Mero-95	10856-111G1	33.75	6.00
mesothelioma cell line:NCI-H2052	10847-111F1	40.75	13.09
mesothelioma cell line:NCI-H226	10846-111E9	42.71	8.51
mesothelioma cell line:NCI-H2452	10848-111F2	35.70	9.22
mesothelioma cell line:NCI-H28	10845-111E8	53.95	12.47
mesothelioma cell line:No36	10857-111G2	41.75	10.76
mesothelioma cell line:ONE58	10858-111G3	51.75	6.23
migratory langerhans cells, donor1	11901-125F2	205.74	44.91
migratory langerhans cells, donor2	11902-125F3	117.60	23.81
migratory langerhans cells, donor3	11903-125F4	110.92	22.79
mixed mullerian tumor cell line:HTMMT	10689-109F5	36.57	11.75
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	13.56	6.15
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	36.40	9.91
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	16.17	4.57
myelodysplastic syndrome cell line:SKM-1	10772-110F7	79.28	13.86
myeloma cell line:PCM6	10474-106I6	52.18	8.70
myxofibrosarcoma cell line:MFH-ino	10600-108E6	20.80	13.19
myxofibrosarcoma cell line:NMFH-1	10684-109E9	30.99	3.73
nasal epithelial cells, donor1, tech_rep1	12226-129F3	47.80	12.93
nasal epithelial cells, donor1, tech_rep2	12226-129F3	51.63	10.66
nasal epithelial cells, donor2	12227-129F4	25.94	7.18
neuroblastoma cell line:CHP-134	10508-107D4	26.46	10.81
neuroblastoma cell line:NB-1	10539-107G8	60.62	17.77
neuroblastoma cell line:NBsusSR	10607-108F4	22.14	6.96
neuroblastoma cell line:NH-12	10555-107I6	40.81	17.89
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	17.08	9.96
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	21.70	13.62
neuroectodermal tumor cell line:TASK1	10774-110F9	23.55	8.86
neuroepithelioma cell line:SK-N-MC	10728-110A8	6.99	13.35
neurofibroma cell line:Hs 53.T	10729-110A9	23.95	5.86
neutrophil PMN, donor1	12133-128D9	0.00	14.87
neutrophil PMN, donor2	12137-128E4	0.00	13.28
neutrophil PMN, donor3	12141-128E8	56.82	9.47
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	77.12	23.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	56.84	35.22
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	28.85	7.69
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	31.27	12.88
nucleus accumbens, adult, pool1	10037-101F1	146.70	49.49
occipital cortex - adult, donor10196	10172-103C1	152.47	61.81
occipital cortex, adult, donor10252	10163-103B1	82.12	36.50
occipital cortex, newborn, donor10223	10355-105E4	111.00	50.22
occipital lobe, adult, donor1	10076-102A4	98.66	50.38
occipital lobe, fetal, donor1	10073-102A1	54.50	36.47
occipital pole, adult, pool1	10036-101E9	125.91	45.33
olfactory region, adult	10195-103E6	100.30	42.99
optic nerve, donor1	10277-104E7	66.03	82.04
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	47.96	13.56
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	54.68	21.71
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	23.20	8.13
oral squamous cell carcinoma cell line:SAS	10544-107H4	43.08	7.05
osteoclastoma cell line:Hs 706.T	10704-109H2	29.40	8.82
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	21.49	6.54
osteosarcoma cell line:HS-Os-1	10558-107I9	30.11	5.51
ovary, adult, pool1	10020-101D2	15.02	6.38
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	19.25	6.05
pancreas, adult, donor1	10049-101G4	28.22	10.35
pancreatic carcinoma cell line:NOR-P1	10698-109G5	28.23	10.34
papillary adenocarcinoma cell line:8505C	10437-106E5	27.43	5.11
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	48.18	7.62
paracentral gyrus, adult, pool1	10035-101E8	147.90	50.61
parietal cortex, adult, donor10258	10373-105G4	117.44	48.44
parietal lobe - adult, donor10196	10171-103B9	133.55	53.61
parietal lobe, adult, donor10252	10157-103A4	104.32	39.05
parietal lobe, adult, pool1	10034-101E7	141.52	43.97
parietal lobe, fetal, donor1	10072-101I9	49.46	45.58
parietal lobe, newborn, donor10223	10356-105E5	119.64	54.96
parotid gland, adult	10199-103F1	9.25	8.02
penis, adult	10200-103F2	17.19	13.96
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	29.94	26.96
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	34.24	15.59
pineal gland - adult, donor10196	10179-103C8	172.87	58.70
pineal gland, adult, donor10252	10160-103A7	200.17	40.27
pineal gland, adult, donor10258	10377-105G8	85.28	45.15
pituitary gland - adult, donor10196	10180-103C9	76.90	20.24
pituitary gland, adult, donor10252	10162-103A9	90.69	19.80
pituitary gland, adult, donor10258	10378-105G9	42.56	9.36
placenta, adult, pool1	10021-101D3	49.13	14.30
plasma cell leukemia cell line:ARH-77	10840-111E3	25.16	5.56
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	24.44	5.14
pons, adult, pool1	10033-101E6	152.68	50.01
postcentral gyrus, adult, pool1	10032-101E5	145.84	44.46
promyelocytes/myelocytes PMC, donor1	12132-128D8	33.46	10.46
promyelocytes/myelocytes PMC, donor2	12136-128E3	38.56	16.52
promyelocytes/myelocytes PMC, donor3	12140-128E7	23.47	0.00
prostate cancer cell line:DU145	10490-107B4	37.87	9.18
prostate cancer cell line:PC-3	10439-106E7	53.91	19.78
prostate, adult, pool1	10022-101D4	19.59	7.89
putamen, adult, donor10196	10176-103C5	144.47	78.37
putamen, adult, donor10252	10152-102I8	90.19	39.21
putamen, adult, donor10258, tech_rep1	10372-105G3	166.11	29.51
putamen, adult, donor10258, tech_rep2	10372-105G3	117.42	61.37
putamen, newborn, donor10223	10365-105F5	125.94	55.47
rectal cancer cell line:TT1TKB	10469-106I1	42.77	6.40
rectum, fetal, donor1	10067-101I4	34.77	13.91
renal cell carcinoma cell line:OS-RC-2	10411-106B6	30.10	7.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	46.39	22.37
retina, adult, pool1	10030-101E3	61.73	26.34
retinoblastoma cell line:Y79	10475-106I7	23.64	7.01
rhabdomyosarcoma cell line:KYM-1	10787-110H4	24.71	10.20
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	22.78	11.81
sacrococcigeal teratoma cell line:HTST	10695-109G2	11.37	3.03
salivary acinar cells, donor1	11771-123I7	22.50	6.15
salivary acinar cells, donor2	11772-123I8	26.71	8.81
salivary acinar cells, donor3	11773-123I9	30.45	12.58
salivary gland, adult, pool1	10093-102C3	44.04	19.45
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	65.09	11.21
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	61.24	12.34
seminal vesicle, adult	10201-103F3	17.99	11.11
serous adenocarcinoma cell line:JHOS-2	10639-108I9	37.17	16.52
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	20.13	4.28
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	24.08	9.03
serous cystadenocarcinoma cell line:HTOA	10693-109F9	82.61	14.91
signet ring carcinoma cell line:Kato III	10436-106E4	31.50	6.19
signet ring carcinoma cell line:NUGC-4	10483-107A6	90.32	17.16
skeletal muscle - soleus muscle, donor1	10282-104F3	65.97	33.34
skeletal muscle, adult, pool1	10023-101D5	16.67	7.32
skeletal muscle, fetal, donor1	10066-101I3	13.07	4.02
skin, adult, donor1	10074-102A2	13.57	13.57
skin, fetal, donor1	10065-101I2	20.83	12.62
small cell cervical cancer cell line:HCSC-1	10800-110I8	28.35	13.34
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	49.17	15.13
small cell lung carcinoma cell line:DMS 144	10841-111E4	18.31	9.44
small cell lung carcinoma cell line:LK-2	10541-107H1	28.68	12.86
small cell lung carcinoma cell line:NCI-H82	10842-111E5	46.49	27.83
small cell lung carcinoma cell line:WA-hT	10562-108A4	42.28	11.11
small intestine, adult, pool1	10024-101D6	85.40	18.16
small intestine, fetal, donor1	10064-101I1	57.00	14.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	57.44	13.34
smooth muscle, adult, pool1	10048-101G3	15.51	8.01
somatostatinoma cell line:QGP-1	10781-110G7	38.06	15.55
spinal cord - adult, donor10196	10181-103D1	83.27	48.40
spinal cord, adult, donor10252	10159-103A6	63.87	27.20
spinal cord, adult, donor10258	10369-105F9	101.69	37.36
spinal cord, fetal, donor1	10056-101H2	60.37	40.86
spinal cord, newborn, donor10223	10359-105E8	99.65	42.25
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	25.84	8.21
spleen, adult, pool1	10025-101D7	52.97	12.11
spleen, fetal, pool1	10044-101F8	68.49	18.04
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	39.13	8.70
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	30.57	8.92
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	34.95	12.93
squamous cell carcinoma cell line:T3M-5	10616-108G4	35.97	9.77
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	56.28	7.88
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	22.03	13.98
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	38.08	13.54
stomach, fetal, donor1	10062-101H8	70.49	43.79
submaxillary gland, adult	10202-103F4	26.77	11.39
substantia nigra - adult, donor10196	10178-103C7	54.27	162.82
substantia nigra, adult, donor10252	10158-103A5	65.64	38.63
substantia nigra, adult, donor10258	10371-105G2	135.52	45.52
substantia nigra, newborn, donor10223	10358-105E7	50.17	44.51
synovial sarcoma cell line:HS-SY-II	10441-106E9	15.59	7.11
temporal lobe, adult, pool1	10031-101E4	138.60	48.06
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	54.84	37.04
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	42.20	24.17
tenocyte, donor1	11763-123H8	20.95	4.54
tenocyte, donor2	11765-123I1	13.73	4.20
tenocyte, donor3	11768-123I4	20.76	4.82
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	92.97	31.95
teratocarcinoma cell line:NCR-G1	10798-110I6	29.29	10.33
teratocarcinoma cell line:PA-1	10807-111A6	32.39	11.93
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	70.46	18.66
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	82.44	31.77
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	95.32	34.46
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	52.11	20.52
testis, adult, pool1	10026-101D8	46.06	16.96
testis, adult, pool2	10096-102C6	89.77	38.79
thalamus - adult, donor10196	10168-103B6	107.09	58.51
thalamus, adult, donor10252	10154-103A1	60.95	37.66
thalamus, adult, donor10258, tech_rep1	10370-105G1	230.94	30.79
thalamus, adult, donor10258, tech_rep2	10370-105G1	63.41	22.23
thalamus, newborn, donor10223	10366-105F6	116.79	40.85
throat, adult	10209-103G2	26.22	13.98
throat, fetal, donor1	10061-101H7	21.63	15.54
thymic carcinoma cell line:Ty-82	10803-111A2	32.99	16.69
thymus, adult, pool1	10027-101D9	33.50	15.51
thymus, fetal, pool1	10043-101F7	60.58	16.11
thyroid carcinoma cell line:KHM-5M	10776-110G2	36.70	9.31
thyroid carcinoma cell line:TCO-1	10783-110G9	23.19	6.01
thyroid, adult, pool1	10028-101E1	39.94	16.80
thyroid, fetal, donor1	10060-101H6	37.18	24.78
tongue epidermis (fungiform papillae), donor1	10288-104F9	21.56	12.32
tongue, adult	10203-103F5	18.14	13.95
tongue, fetal, donor1	10059-101H5	21.28	9.85
tonsil, adult, pool1	10047-101G2	48.28	14.22
trachea, adult, pool1	10029-101E2	35.66	10.72
trachea, fetal, donor1	10058-101H4	23.47	15.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	36.84	7.44
transitional-cell carcinoma cell line:5637	10418-106C4	25.03	5.67
transitional-cell carcinoma cell line:JMSU1	10492-107B6	69.26	21.78
tridermal teratoma cell line:HGRT	10694-109G1	13.32	3.81
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	32.68	10.16
umbilical cord, fetal, donor1	10057-101H3	35.47	6.26
uterus, adult, pool1	10100-102D1	26.96	11.43
uterus, fetal, donor1	10055-101H1	18.94	14.85
vagina, adult	10204-103F6	22.62	12.92
vein, adult	10191-103E2	21.92	12.28
xeroderma pigentosum b cell line:XPL 17	10563-108A5	18.43	3.47